In a report released today, Jo Walton from UBS maintained a Buy rating on Novo Nordisk (0QIU – Research Report), with a price target of DKK750.00. The company’s shares closed yesterday at ...

Bearish flow noted in Novo Nordisk (NVO) with 7,917 puts trading, or 1.2x expected. Most active are 3/14 weekly 76 puts and Sep-25 110 puts, with total volume in those strikes near 4,100 contracts.

Novo Holdings' $16.5 billion acquisition of US contract development and manufacturing organisation (CDMO) Catalent has been completed, after months of debate over potential antitrust issues.

Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made safely ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

When you’re looking for brilliant things to do in Bahrain, it can be difficult to narrow it down. There are so many must-see attractions and cultural sites in Bahrain. Plus, tons of restaurants, bars, ...

If you thought 2024 was popping, you ain’t seen nothing yet. The 2025 Bahrain events calendar features tons of awesome festivals, parties, new openings, and more. You might also like: The best iftars ...

After hours: March 14 at 7:59:58 p.m. EDT Loading Chart for NVO ...